On the Surface

More documents

Recommendations

Info

“ We have created a safer and better environment... patients recover quicker, hospital stays are shorter and this ultimately reduces cost.” — Dr. Greg Ribakove, M.D. Chief of Cardiac Surgery Bellevue Hospital Center and NYU Medical Center, NYC STERIS CORPORATION PG 8
ON THE SURFACE Behind the Names Technology and commitment power solutions for Customers. The STERIS and Amsco names have long been synonymous with innovation in sterile processing. A key reason for that is our fundamental commitment to develop innovative sterilization, decontamination and infection control products for healthcare, scientific, research, industrial, and government Customers throughout the world. In fact, we have greatly advanced the science of sterility and hold more than 1,000 U.S. and foreign patents. The result is a steady stream of breakthroughs and new applications. As stand-alone units and as complementary components of a complete solution, these products help our Customers improve quality, safety and efficiency. Here are just a few recent innovations: Reliance ® Vision Washer/Disinfector. Customer input and innovative engineering came together in this truly new washing system, featuring redesigned spray arms for more thorough cleaning of critical instruments and utensils. Amsco ® V-PRO 1 Low Temperature Sterilization System. Utilizing vaporized hydrogen peroxide technology, the V-PRO 1 enables efficient processing of large volumes of heat- and moisture-sensitive devices and ensures patient and staff safety. Amsco ® Evolution Steam Sterilizer. A dramatic redesign of Evolution’s controls and displays provides sterile processing departments greater throughput, reduced downtime and improved efficiency, while its modular design allows for ease of installation, operation and servicing. Amsco ® Evolution is currently available only in Europe and is targeted for launch in the United States in fiscal 2009. Prolystica ® Cleaning Chemistries. New concentrated formulations provide remarkable cleaning efficacy, instrument protection, biodegradable ingredients and consistent dilutions at a fraction of the volume of traditional cleaning chemistries. Verify ® SixCess Challenge Packs and Indicator Strips. These chemical indicators provide a high level of assurance that surgical instruments have been properly sterilized and are safe to use immediately. ErgoStat Prep and Pack Workstations. Intelligent ergonomic features such as electric height adjustment distinguish this innovative, flexible instrument reprocessing workstation. Instrument Management Solutions. STERIS has teamed up with Censis Technologies, Inc., the expert in Web-based surgical instrument management systems, to provide a suite of instrument management solutions. The underlying technologies and chemistries are diverse and complex, but the goal is always the same: To enhance Customer productivity and quality, and help make the world a safer place. PG 9
Page 1 and 2: On the Surface FISCAL 2008 ANNUAL R
Page 3 and 4: “ We intend to give Customers mor
Page 5 and 6: ON THE SURFACE NET REVENUES and ded
Page 7 and 8: ON THE SURFACE large population of
Page 9: ON THE SURFACE Advanced Visualizati
Page 13 and 14: ON THE SURFACE Customer-Centric Com
Page 15 and 16: United States Securities and Exchan
Page 17 and 18: PART I Throughout this Annual Repor
Page 19 and 20: support services such as constructi
Page 21 and 22: Restructuring - European Restructur
Page 23 and 24: we cannot assure you that future or
Page 25 and 26: Our success depends, in part, on ou
Page 27 and 28: We conduct manufacturing, sales and
Page 29 and 30: • consent decree, which could res
Page 31 and 32: U.S. Locations (including Puerto Ri
Page 33 and 34: We believe we have adequately reser
Page 35 and 36: PART II ITEM 5. MARKET FOR REGISTRA
Page 37 and 38: ITEM 6. SELECTED FINANCIAL DATA Yea
Page 39 and 40: We use this measure to gauge our ab
Page 41 and 42: A detailed discussion of our fiscal
Page 43 and 44: FISCAL 2008 AS COMPARED TO FISCAL 2
Page 45 and 46: Compensation and benefit costs, fee
Page 47 and 48: Liabilities related to restructurin
Page 49 and 50: We operate in three reportable busi
Page 51 and 52: STERIS Isomedix Services segment op
Page 53 and 54: Operating Expenses. The following t
Page 55 and 56: March 31, 2006 European Restructuri
Page 57 and 58: The following table compares our re
Page 59 and 60: Net Cash Provided by Operating Acti
Page 61 and 62:
• Stock option and other equity t
Page 63 and 64:
CONTRACTUAL AND COMMERCIAL COMMITME
Page 65 and 66:
Allowance for Sales Returns. We mai
Page 67 and 68:
Our self-insured liabilities contai
Page 69 and 70:
Amendment of FASB Statements No. 87
Page 71 and 72:
Item 7A. Quantitative and Qualitati
Page 73 and 74:
REPORT OF MANAGEMENT Board of Direc
Page 75 and 76:
STERIS CORPORATION AND SUBSIDIARIES
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
9. INCOME TAXES STERIS CORPORATION
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
ITEM 9A. CONTROLS AND PROCEDURES EV
Page 123 and 124:
ITEM 9B. OTHER INFORMATION None. PA
Page 125 and 126:
PART IV ITEM 15. EXHIBITS AND FINAN
Page 127 and 128:
Exhibit Number Exhibit Description
Page 129 and 130:
EXHIBIT INDEX Exhibit Number Exhibi
Page 131 and 132:
Exhibit Number Exhibit Description
Page 133 and 134:
EXHIBIT 23.1 CONSENT OF INDEPENDENT
Page 135 and 136:
EXHIBIT 31.1 CERTIFICATION OF THE P
Page 137 and 138:
EXHIBIT 32.1 CERTIFICATION PURSUANT
Page 139 and 140:
Corporate Information BOARD OF DIRE
show all

On the Surface

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?